Nancy Reau, MD, section chief of hepatology at Rush University Medical Center, elaborates on survey results showing providers have varying awareness and understanding on guidelines for chronic liver disease.
Nancy Reau, MD, section chief of hepatology at Rush University Medical Center, elaborates on survey results published in the Salix Liver Health Annual Trends Report, showing providers have varying awareness and understanding on guidelines for chronic liver disease (CLD).
According to a survey of more than 400 health care providers, 38% said were not aware of and/or could not name national guidelines for the management of CLD, and using the American Association for the Study of Liver Diseases (AASLD) guidelines was more of a priority for gastroenterologists (82%) compared with all other providers.
Transcript
Why did you include nurse practitioners and physician assistants in the survey?
Adding nurse practitioners and physician assistants to the survey was really important. We know that primary care is often managed quite a bit by our APPs [advanced practice providers] and, even within subspecialty care and inpatient management, they are a very critical, important practice. So some of our patients really do find that the bulk of their care is provided by APPs, and so if we don't survey them, we don't really understand this critical component in our patients' management.
Why was there such a high number of respondents who were unaware of or could not name national guidelines for chronic liver disease management?
National guidelines come from lots of different places. When you're a liver specialist, it's easy for us to look at the American Liver Association or the European Liver Association and know that they've got reliable guidelines, and we tend to, as members, get alerts when these guidelines are updated or when a new guideline is released. If you're a gastroenterologist or if you're a primary care physician, your resource for your guidelines is going to be a little bit different.
Now, as a GI [gastroenterologist], American College of Gastroenterology as well as AGA [American Gastroenterology Association] do release liver-associated or liver-centric guidelines, and they should be aware of some of that. But when you start to move into the community, especially if you're not doing fellow education or you're looking at that very busy day that you've gone through and you're getting your big journal and you're looking at the titles, you might not remember—especially if it didn't seem relevant to you at that day when you were doing screening colonoscopy and taking care of reflux disease—that there was a new guideline released on hemochromatosis. So I think a lot of our community physicians do find that they might not be aware of things just because it's not as well highlighted as it would be in an academic institution where we're consistently being challenged by our fellows or we're responsible for fellow education and we tend to be a little bit more aware of when these new releases occur.
Plus, we tend to find that our metrics are a little more aligned with guideline-supported management. What I mean by that is that, if you're teaching fellows or if you have residents that you're you're educating, you tend to try to at least know what the guidelines are so that if you're going against them, you can at least say, "our guidelines would suggest we might be doing this, but this is the reason that we're not following the guidelines right now." I would imagine that occurs a lot less in the community practices.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More